User:Carlos Vázquez García/TFG
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
<span style="display:block;margin-left:20px;margin-top:0px;margin-bottom:10px;">Índice de contenidos</span> | <span style="display:block;margin-left:20px;margin-top:0px;margin-bottom:10px;">Índice de contenidos</span> | ||
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:20px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte1#punto1 | 1. Resumen / Abstract]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:20px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte1#punto2 | 2. Palabras clave / Keywords]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:20px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte1#punto3 | 3. Introducción]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:20px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte1#punto4 | 4. Objetivos]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:20px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte1#punto5 | 5. Metodología y Materiales]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:30px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte1#punto51 | 5.1. Metodología]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:30px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte1#punto52 | 5.2. Materiales]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:20px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte2#punto6 | 6. Desarrollo, resultados y discusión]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:30px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte2#punto61 | 6.1. Estudio de las estructuras primaria, secundaria y terciaria de K-RAS]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte2#punto611 | 6.1.1. Análisis de la estructura primaria]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte2#punto612 | 6.1.2. Análisis de la estructura secundaria]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte2#punto613 | 6.1.3. Análisis de la estructura terciaria]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:30px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte3#punto62 | 6.2. Función y Mecanismo de K-RAS. Ligandos y sitios de unión]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte3#punto621 | 6.2.1. Mecanismo de activación e inactivación de K-RAS]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte3#punto622 | 6.2.2. Bolsillo de la proteína]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte4#punto623 | 6.2.3. Guanosín 5'-trifosfato (GTP)]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte4#punto624 | 6.2.4. Guanosín 5'-difosfato (GDP)]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte4#punto625 | 6.2.5. Catión Magnesio <sup>2+</sup>]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte5#punto626 | 6.2.6. Nuevos ligandos]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:50px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte5#punto6261 | 6.2.6.1. 4-bromobenzotiol]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:50px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte5#punto6262 | 6.2.6.2. Benzimidina]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:50px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte5#punto6263 | 6.2.6.3. Etinilsulfonamida]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:30px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte6#punto63 | 6.3. Mutaciones en K-RAS]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte6#punto631 | 6.3.1. Leucemia]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte6#punto632 | 6.3.2. Cáncer de pulmón]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:40px;display:block;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte6#punto633 | 6.3.3. Cáncer gástrico]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:20px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte6#punto7 | 7. Conclusiones]]</span> |
| - | <span style="line-height: | + | <span style="line-height:24px;font-size:14px;margin-left:20px;display:block;font-weight:bold;">[[User:Carlos_V%C3%A1zquez_Garc%C3%ADa/TFG/Parte7#punto8 | 8. Bibliografía]]</span> |
</div> | </div> | ||
|} | |} | ||
